


Kynetyka Technologies Pty Revenue
Medical Equipment Manufacturing • Geelong, Victoria, Australia • 1-10 Employees
Kynetyka Technologies Pty revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Kynetyka Technologies Pty
Craig Newton
CEO and Managing Director
Company overview
| Headquarters | 22 Seaview Pde, Belmont, Victoria 3216, AU |
| Phone number | +61434674256 |
| Website | |
| SIC | 581 |
| Keywords | Digital Health, Point-Of-Care Testing, Deep Vein Thrombosis Screening, Software-As-A-Medical-Device |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Kynetyka Technologies Pty Email Formats
Kynetyka Technologies Pty uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@kynetyka.com.au), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@kynetyka.com.au | 100% |
About Kynetyka Technologies Pty
Kynetyka Technologies Pty Ltd is an Australian medical device company headquartered in Adelaide. Kynetyka is developing and commercialising DVTect®, a unique, patented, point-of-care device designed to detect deep vein thrombosis (DVT) quickly and accurately. Kynetyka is led by a team of experienced professionals, supported by leading clinical and technology advisors. The executive team has collectively over 120 years of global experience in the medical, pharmaceutical, and technology development sectors. They have the skills and knowledge to expedite development and commercialise DVTect®, improving detection and diagnosis of DVT, enhancing patient outcomes, and ultimately saving lives. DVTect® combines software and sensor technology to detect DVT. It is portable, affordable, and simple to use. It is designed for use by healthcare professionals and also non- medically trained personnel. When a patient has a DVT in the leg, there is a measurable change in the calf muscle’s response to movement. The DVTect® sensor is attached to the leg, which is lightly tapped to cause movement in the muscle. The sensor captures the resulting 3D waveform data and transmits it to the DVTect® software, which analyses the signal to detect the presence of DVT. Results are displayed instantly on a smart device or computer. DVTect® is faster and easier to use than ultrasound devices. It has the potential to reduce unnecessary ultrasounds, avoid preventable deaths from pulmonary embolism, and the overuse of anticoagulants. Use of DVTect® could result in an estimated healthcare cost saving of over $4 billion per year in the USA and Australia. Currently in development, DVTect® is initially targeted for use in hospitals, including post-surgery wards, intensive care units, and emergency departments. Future expansion will introduce DVTect® into community settings including general practice/primary care, aged care, maternal health and regional and remote communities.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Kynetyka Technologies Pty has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Kynetyka Technologies Pty has never raised funding before.
Kynetyka Technologies Pty Tech Stack
Discover the technologies and tools that power Kynetyka Technologies Pty's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Web servers
JavaScript libraries
Programming languages
Blogs
Hosting
UI frameworks
Video players
SEO
Photo galleries
Frequently asked questions
4.8
40,000 users



